Clinical trial Recruiting at 1 site Observational Ages 18 to 70

Shortening the Oral Sodium Loading Test for Diagnosing Primary Aldosteronism

Official title: Consistency of 24-hour Urinary Aldosterone on on the Second Day and the Third Day in Diagnosis of Primary Aldosteronism Measured in the Oral Sodium Loading Test by Liquid Chromatography-tandem Mass Spectrometry

Run by Peking Union Medical College Hospital · NCT06750172 · Data updated 2026-11-12

This study is testing if a shorter 2-day sodium loading test can accurately diagnose primary aldosteronism, compared to the traditional 3-day method, for people with this condition.

More Primary Aldosteronism trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment33 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 15, 2023
Main results expectedDecember 25, 2024
Study endsDecember 25, 2024
Registry record updatedDecember 27, 2024
Trial IDNCT06750172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 20-70 with hypertension and hypokalemia diagnosed with primary aldosteronism.

Probably not a fit

Patients with other causes of endocrine hypertension or significant comorbid conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare the effectiveness of a 2-day oral sodium loading test against the traditional 3-day method for diagnosing primary aldosteronism. It involves 17 healthy controls and 15 patients diagnosed with primary aldosteronism, who will follow a high-sodium diet for 3 days. The study will measure 24-hour urinary aldosterone levels on both the second and third days to determine if the shorter test can reliably replace the longer one. The goal is to simplify the diagnostic process while maintaining accuracy.

Why it matters

Potential benefit: If successful, this study could streamline the diagnostic process for primary aldosteronism, making it less burdensome for patients.

How similar studies have gone: While this approach is exploratory, similar studies have shown promise in simplifying diagnostic methods for endocrine disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
PA patients:

Inclusion criteria:

* Patients with hypertension and hypokalemia who have been diagnosed with primary aldosteronism following the latest version international guidelines for primary aldosteronism.
* Age: 20-70 years old, male and female;
* BMI: 18.5-23.9 kg/m2;

Exclusion criteria:

* Other causes of endocrine hypertension including pheochromocytoma, Cushing syndrome, etc.
* Renal artery stenosis and low potassium due to other factors, such as renal tubular acidosis, Bartter syndrome, Gitelman syndrome, etc.
* History of hyperthyroidism, hepatic and renal insufficiency, malignant tumors, metabolic diseases, cardiovascular diseases, and mental diseases,menstrual disorders Healthy volunteers

Inclusion criteria:

* Age: 20-70 years old, male and female;
* BMI: 18.5-23.9 kg/m2;
* Blood pressure: 90-120/60-80 mmHg on three consecutive office blood pressure readings;
* Female must have regular menstrual cycle (blood and urine samples should be taken during the non-menstrual period);
* Regular dietary habits;
* No medications taken within the past 1 month.

Exclusion criteria:

* History of hypokalemia.
* History of liver and kidney dysfunction, malignant tumors, metabolic disorders, cardiovascular diseases, and psychiatric disorders, etc.
* Menstrual irregularities and taking contraceptive pills.
* History of hypertension
* Have taken any drugs including anti-inflammatory drugs, potassium diuretics, or special health products in the 4 weeks prior to the examination,

Where it's running

  • Peking Union Medical College Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.